This sponsor had blockbuster expectations for its compound in the treatment of moderate-to-severe atopic dermatitis when it began its Phase III study.
Atopic Dermatitis
Randomized patients delivered: | 25% |
Enrollment cost saved: | $2.2 million |


This sponsor had blockbuster expectations for its compound in the treatment of moderate-to-severe atopic dermatitis when it began its Phase III study.
Randomized patients delivered: | 25% |
Enrollment cost saved: | $2.2 million |